Diah Kusumawaty Kusumawaty

Dr. Diah Kusumawaty Kusumawaty

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Reviews in Medical Virology
Verified
Journal Article
Closed access
Trina E. TalleiTrina E. Tallei
Trina E. Tallei
Saad AlhumaidSaad Alhumaid
Saad Alhumaid
ZAZainab AlMusa
Zainab AlMusa
FFFatimawali F Fatimawali
Fatimawali F Fatimawali
DKDiah Kusumawaty Kusumawaty
Diah Kusumawaty Kusumawaty
ARAli A. Rabaan
Ali A. Rabaan

1 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Trina E. TalleiTrina E. Tallei
Trina E. Tallei
FFFatimawali F Fatimawali
Fatimawali F Fatimawali
AAAhmad Akroman Adam
Ahmad Akroman Adam
MEMona M. Elseehy
Mona M. Elseehy
AEAhmed El-Shehawi
Ahmed El-Shehawi
TETalha Bin Emran
Talha Bin Emran
Before entering the cell, the SARS-CoV-2 spike glycoprotein receptor-binding domain (RBD) binds to the human angiotensin-converting enzyme 2 (hACE2) receptor. Hence, this RBD is a critical target for the development of antiviral agents. Recent studies have discovered that SARS-CoV-2 variants with mutations in the RBD have spread globally. The purpose of this in silico study was to determine the potential of a fruit bromelain-derived peptide. DYGAVNEVK. to inhibit the entry of various SARS-CoV-2 variants into human cells by targeting the hACE binding site within the RBD. Molecular docking analysis revealed that DYGAVNEVK interacts with several critical RBD binding residues responsible for the adhesion of the RBD to hACE2. Moreover, 100 ns MD simulations revealed stable interactions between DYGAVNEVK and RBD variants derived from the trajectory of root-mean-square deviation (RMSD), radius of gyration (Rg), and root-mean-square fluctuation (RMSF) analysis, as well as free binding energy calculations. Overall, our computational results indicate that DYGAVNEVK warrants further investigation as a candidate for preventing SARS-CoV-2 due to its interaction with the RBD of SARS-CoV-2 variants.

29 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Abdul Hawil AbasAbdul Hawil Abas
Abdul Hawil Abas
SMSiti Marfuah
Siti Marfuah
Rinaldi IdroesRinaldi Idroes
Rinaldi Idroes
DKDiah Kusumawaty Kusumawaty
Diah Kusumawaty Kusumawaty
FFFatimawali F Fatimawali
Fatimawali F Fatimawali
Bonglee KimBonglee Kim
Bonglee Kim
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination.

24 April 2022 in Fermentation
Verified
Journal Article
Open access
PDF file
Trina E. TalleiTrina E. Tallei
Trina E. Tallei
FFFatimawali F Fatimawali
Fatimawali F Fatimawali
AYAfriza Yelnetty
Afriza Yelnetty
DKDiah Kusumawaty Kusumawaty
Diah Kusumawaty Kusumawaty
YEYunus Effendi
Yunus Effendi
Bonglee KimBonglee Kim
Bonglee Kim
Pineapple peel (PP) is a by-product with the potential to be used as a raw material for functional beverages. Traditional PP fermentation has so far paid little attention to the microbial community and its role in the fermentation process. As a result, the current research looked into the microbial communities and their roles during PP fermentation. A metagenomic approach based on the 16S rRNA sequencing data was used to assess the microbial communities. Subsequent analysis was performed using PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states) to analyze the microbial functions in the fermentation system. The microecology of the fermentation process in three samples was predominated by Firmicutes. Furthermore, the well-known probiotic genera Weissella, Lactobacillus, and Lactococcus were found to be predominating in the gumer, promic, and control samples, respectively. It was obvious that microenvironmental differences have an effect on the microbial composition of PP fermentation. Moreover, functional prediction revealed that carbohydrate metabolism was the most prevalent metabolic pathway during the fermentation process. Additionally, it was discovered that all of the bacteria found in the samples played significant roles in carbohydrate, amino acid, vitamin, and co-factor metabolism, which can be inferred to result in the production of beneficial metabolites.


Verified
Journal Article
Open access
PDF file
NHNovia Hanasti
Novia Hanasti
LFLia Faridah
Lia Faridah
AFAzzania Fibriani
Azzania Fibriani
HWhesti lina wiraswati
hesti lina wiraswati
DKDiah Kusumawaty Kusumawaty
Diah Kusumawaty Kusumawaty
SESavira Ekawardhani
Savira Ekawardhani
Cell culture is an important tool in biological research. Most studies use 2D cell culture, but cells grown in 2D cell culture have drawbacks, including limited cell and cell-extracellular matrix interactions, which make it inaccurate to model conditions in vivo. Anticancer drug screening is an important research and development process for developing new drugs. As an experiment to mimic the cancer environment in vivo, several studies have been carried out on 3-dimensional (3D) cell cultures with added biomaterials. The use of hydrogel in 3D culture cells is currently developing. The type of hydrogel used might influence cell morphology, viability, and drug screening outcome. Therefore, this review discusses 3D cell culture research regarding the addition of biomaterials.